Mubadala Bio and Eli Lilly Announce Pharmaceutical Packaging and Logistics Collaboration

On 20 October 2026, Mubadala Bio and Eli Lilly announced a strategic collaboration to advance the local packaging and logistics of Lilly’s GLP-1 medicines in Abu Dhabi. The commercial value was not disclosed, but the agreement highlights potential demand for pharmaceutical manufacturing support, supply-chain systems and temperature-sensitive logistics analytics; contact HPC for a quotation on operational data processing and computing infrastructure.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.